Where deep cellular insight meets real-time clinical action
The future of care isn't just treating disease, it is preventing the systemic decay that causes it. Harnessing real-time predictive models, AI decodes vast streams of patient data in milliseconds. Doctors can see what human eyes miss, turning reactive treatments into proactive, lifelong protection.
Deep learning meets echocardiography — our AI parses ultrasound signals in real time, flagging structural defects the eye might miss. Early. Precise. Actionable.
Congenital heart disease affects roughly 1 in 100 live births, and early, accurate detection materially changes surgical outcomes. Most diagnostic AI in this space is trained to answer a narrow question in isolation: is this view normal or abnormal. We build the full pipeline instead, from raw echocardiography acquisition through view classification, structural measurement, and surgical outcome prediction, so a clinician gets a single coherent read rather than a stack of disconnected model outputs to reconcile themselves.
Our models are developed with clinicians trained at MIT and Harvard, published in peer-reviewed venues supported by the NIH and the American Heart Association, and validated against real surgical outcomes, not just retrospective image labels. That grounding matters in a clinical setting: a system used in fetal and perinatal cardiology has to be explainable to the physician making the call, auditable after the fact, and precise enough that its output changes a real decision rather than adding another dashboard to check.
The model identifies which echocardiographic view is being captured — A4C, PLAX, PSAX, subcostal — enabling downstream algorithms to apply view-specific analysis without operator labelling.
A segmentation model delineates all four chambers simultaneously — LV, RV, LA, RA — enabling precise automated measurement of volumes, wall thickness, and chamber dimensions throughout the cardiac cycle.
The diagnostic head runs multi-label classification across CHD types — ASD, VSD, Tetralogy of Fallot, hypoplastic left heart syndrome, coarctation of aorta — returning confidence scores and localised bounding boxes for each suspected defect.
The national average prenatal detection rate for congenital heart disease sits close to 50 percent. Some defects are caught almost every time. Others are missed far more often, not because clinicians are careless, but because a standard four chamber screening view simply cannot show every lesion.
This is the gap AI assisted screening is built to close. It does not replace the standard four chamber view. It adds a second, tireless set of eyes that never skips a frame, flags the views that are hardest for humans to catch consistently, and applies the same threshold every time, regardless of how late in the day or how busy the clinic is.
Claims about AI in medicine are easy to make and hard to verify. The numbers below come from a pooled 2024 systematic review and meta-analysis covering seven independent studies and nineteen datasets of AI assisted fetal echocardiographic image analysis, not from a single vendor's internal testing.
People living in rural and remote areas have the lowest access to cardiac imaging. AI guided point of care ultrasound lets a non-expert operator capture diagnostic quality images, close to 80 percent of the time on standard views, without a sonographer on site.
Harder views remain more variable, so this does not replace specialist interpretation. It extends where a first, reliable image can be taken at all, directly addressing the access gap described in the previous section.